• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 6-K filed by Check-Cap Ltd.

    1/30/26 5:00:20 PM ET
    $MBAI
    Medical Electronics
    Health Care
    Get the next $MBAI alert in real time by email
    6-K 1 ea0274731-6k_checkcap.htm REPORT OF FOREIGN PRIVATE ISSUER

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

    FORM 6-K

     

    REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16

    OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934

     

    For the month of January 2026.

     

    Commission File Number 001-36848

     

    Check-Cap Ltd.

    (Exact Name of Registrant as Specified in Charter)

     

    Abba Hushi Avenue
    P.O. Box 1271
    Isfiya, 30090 Mount Carmel, Israel
    (Address of principal executive offices)

     

    Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

     

    Form 20-F ☒      Form 40-F ☐

     

     

     

     

     

     

    This Form 6-K is being incorporated by reference into Check-Cap Ltd.’s Registration Statements on Form F-3 (File No. 333-262401) and Form S-8 (File No. 333-203384, 333-226490 and 333-259666) filed with the Securities and Exchange Commission, to be a part thereof from the date on which this Report is submitted, to the extent not superseded by documents or reports subsequently filed or furnished.

     

    Financial Information Regarding Merger with Mbody AI Corp.

     

    As previously disclosed, at the Annual General Meeting of Shareholders of Check-Cap Ltd. (the “Company” or “Check-Cap”) held on November 14, 2025, shareholders of the Company approved the merger (the “Merger”) of CC Merger Sub Inc., a Nevada corporation and a direct, wholly owned subsidiary of Check-Cap (the “Merger Sub”), with and into MBody AI Corp., a Nevada corporation (“MBody AI”), with MBody AI surviving and becoming a wholly-owned subsidiary of Check-Cap after the Merger, pursuant to an Agreement and Plan of Merger (the “Merger Agreement”), dated as of September 12, 2025, by and among MBody AI, the Merger Sub and Check-Cap.

     

    Check-Cap and MBody AI continue to work towards closing the Merger and are filing the financial statements contained in the exhibits below in furtherance of the transaction. Check-Cap and MBody AI expect the Merger to consummate in the first half of 2026; however, the timing of the completion of the Merger is subject to various conditions and uncertainties, including the availability of sufficient capital to satisfy Nasdaq listing requirements and the completion of regulatory and exchange review processes, and there can be no assurance that the Merger will be completed within this timeframe or at all.

     

    The financial statements of MBody AI as of December 31, 2024 and for the period from October 7, 2024 (date of formation) to December 31, 2024, and as of June 30, 2025 and for the six months then ended, have been audited by BCRG Group, an independent registered public accounting firm registered with the Public Company Accounting Oversight Board, as set forth in their report thereon. The audited financial statements and the auditor's report are attached hereto as Exhibit 99.1 and are incorporated herein by reference.

     

    The unaudited pro forma condensed combined balance sheet as of December 31, 2024 and June 30, 2025, and the unaudited pro forma condensed combined statements of operations for the six months ended June 30, 2025 and for the period from October 7, 2024 (date of formation) to December 31, 2024 are filed as Exhibit 99.2 hereto and are incorporated herein by reference. The unaudited pro forma condensed combined financial information that has been included as Exhibit 99.2 to this Report of Foreign Private Issuer on Form 6-K does not necessarily reflect what the Company’s results of operations, financial position or cash flows would have been during the periods presented had the Merger been completed in prior periods and does not necessarily indicate what the Company’s results of operations, financial position, cash flows or costs and expenses will be in the future.

     

    Cautionary Statement Concerning Forward-Looking Statements

     

    This Report on Form 6-K contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements other than statements of historical fact are forward-looking statements, which include, among others, statements regarding the completion and timing of the Merger, the Company’s ability to maintain continued compliance with Nasdaq listing requirements, and the expected benefits of the Merger. These forward-looking statements are based on the Company’s current intentions, beliefs, and expectations regarding future events. Actual results may differ materially due to risks and uncertainties including, but not limited to, the satisfaction of closing conditions, the ability to complete the Merger on the anticipated timeline or at all, integration risks, customer concentration risks including the potential loss or termination of key customer contracts, the ability to develop and commercialize new products and features, market conditions, and other factors described in the Company’s Annual Report on Form 20-F filed with the U.S. Securities and Exchange Commission on August 27, 2025. The Company undertakes no obligation to update forward-looking statements except as required by law.

     

    1

     

     

    Exhibits

     

    Exhibit No.   Description
    99.1   Consolidated Audited Financial Statements of MBody AI Corp. as of December 31, 2024 and June 30, 2025, and for the period from October 7, 2024 (date of formation) to December 31, 2024, and for the six months ended June 30, 2025
    99.2   Unaudited pro forma condensed combined financial information  
    99.3   Consent of Independent Registered Public Accounting Firm

     

    2

     

     

    SIGNATURES

     

    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

     

      CHECK-CAP LTD.
       
      By: /s/ David Lontini
      Name:  David Lontini
      Title: Interim Chief Executive Officer

     

    Date: January 30, 2026

     

     

    3

     

     

    Get the next $MBAI alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $MBAI

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $MBAI
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Check-Cap Clears Key Nasdaq Requirement, Advancing MBody AI Merger Toward Completion

    ISFIYA, Israel, Jan. 26, 2026 (GLOBE NEWSWIRE) -- Check-Cap Ltd. (NASDAQ:MBAI) ("Check-Cap" or the "Company") today announced that it has received written confirmation from the Nasdaq Listing Qualifications Department that the Company has regained compliance with Nasdaq's minimum shareholders' equity requirements pursuant to Nasdaq Listing Rule 5550(b). This confirmation clears a key regulatory requirement and represents a significant positive milestone as Check-Cap advances toward completion of its previously announced, shareholder-approved merger with MBody AI. The merger is expected to transform Check-Cap into a publicly traded leader in embodied artificial intelligence, subject to c

    1/26/26 9:50:00 AM ET
    $MBAI
    Medical Electronics
    Health Care

    $MBAI
    SEC Filings

    View All

    SEC Form F-1 filed by Check-Cap Ltd.

    F-1 - Check-Cap Ltd (0001610590) (Filer)

    1/30/26 5:28:42 PM ET
    $MBAI
    Medical Electronics
    Health Care

    SEC Form 6-K filed by Check-Cap Ltd.

    6-K - Check-Cap Ltd (0001610590) (Filer)

    1/30/26 5:00:20 PM ET
    $MBAI
    Medical Electronics
    Health Care

    SEC Form 6-K filed by Check-Cap Ltd.

    6-K - Check-Cap Ltd (0001610590) (Filer)

    1/26/26 8:35:18 AM ET
    $MBAI
    Medical Electronics
    Health Care